(Q35874060)

10 August 2017

1 reference

title

West Nile virus: where are we now? (English)

1 reference

10 August 2017

0 references

Gerald A Campbell

6

0 references

Alan D T Barrett

7

object named as

Alan D T Barrett

1 reference

10 August 2017

3

Stephen Higgs

1 reference

10 August 2017

Bruno P Granwehr

1

1 reference

10 August 2017

Kristy M Lillibridge

2

1 reference

10 August 2017

Peter W Mason

4

1 reference

10 August 2017

Judith F Aronson

5

1 reference

10 August 2017

1 September 2004

1 reference

Lancet Infectious Diseases

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

547-556

1 reference

10 August 2017

9

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

10 August 2017

1 reference

7 January 2021

The epidemic of West Nile virus in the United States, 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Morphologic and Molecular Characterization of New Cyclospora Species from Ethiopian Monkeys: C. cercopitheci sp.n., C. colobi sp.n., and C. papionis sp.n

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile Virus in OverwinteringCulexMosquitoes, New York City, 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Emerging Vectors in the Culex pipiens Complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

The potential for West Nile virus to establish outside of its natural range: a consideration of potential mosquito vectors in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Intrauterine West Nile virus: ocular and systemic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Transmission of West Nile virus from an organ donor to four transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus in Mexico: evidence of widespread circulation since July 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

The outbreak of West Nile virus infection in the New York City area in 1999

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

1 reference

7 January 2021

West Nile Virus Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Diabetes and hypertension physiopathology and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Effect of losartan on the blood–brain barrier permeability in diabetic hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Studies on the permeability of the blood-brain barrier in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Central nervous system complications of diabetes mellitus--a perspective from the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Atypical West Nile virus infection in a child

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus meningoencephalitis complicated by motor aphasia in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus encephalitis in a child with left-side weakness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus: a primer for the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Neurologic manifestations and outcome of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Persistence of Japanese encephalitis virus in the human nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus infection: a new acute paralytic illness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

A poliomyelitis-like syndrome from West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Acute flaccid paralysis and West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Electrodiagnostic features of acute paralytic poliomyelitis associated with West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Bilateral diaphragmatic paralysis and related respiratory complications in a patient with West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Clinical and electrophysiologic patterns of flaccid paralysis due to West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Transient parkinsonism in West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus-associated optic neuritis and chorioretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Vitritis and chorioretinitis in a patient with West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Chorioretinal lesions in nonfatal cases of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Occlusive vasculitis in a patient with concomitant West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Uveitis Associated With West Nile Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus meningoencephalitis with optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Urinary retention in a patient with West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Neuropathological findings in West Nile virus encephalitis: A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Fatal West Nile Virus Encephalitis in a Renal Transplant Recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Muscle weakness in West Nile encephalitis is due to destruction of motor neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

The pathology of human West Nile Virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Infection and injury of neurons by West Nile encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Surgical reconstruction of TMJ

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Identification of active antiviral compounds against a New York isolate of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Antiviral effects of an iminosugar derivative on flavivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

Serologic evidence of West Nile virus transmission, Jamaica, West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901128-4

7 January 2021

10.1016/S1473-3099(04)01128-4

Identifiers

DOI

1 reference

10 August 2017

1 reference